Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001072613-25-000364·NEW ENTERPRISE ASSOCIATES 13 LP
Schedule 13G ownership disclosure
Sagimet Biosciences Inc
Series A Common Stock, $0.0001 par value per share · CUSIP: 786700104
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- New Enterprise Associates 13, L.P.
Shares: 0.00 · Class: 0%
- NEA Partners 13, L.P.
Shares: 0.00 · Class: 0%
- NEA 13 GP, LTD
Shares: 0.00 · Class: 0%
- Forest Baskett
Shares: 0.00 · Class: 0%
- Anthony A. Florence, Jr.
Shares: 0.00 · Class: 0%
- Patrick J. Kerins
Shares: 0.00 · Class: 0%
- Mohamad H. Makhzoumi
Shares: 0.00 · Class: 0%
- Scott D. Sandell
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-25-000364
- Form type
- SCHEDULE 13G/A
- Filer
- NEW ENTERPRISE ASSOCIATES 13 LP
- CIK
- CIK 1452907
- Filed
- May 13, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership